Company intelligence / Profile preview

Standard Life Investments

Edinburgh, Scotland, United Kingdom

Ownership: Private
Development stage: Other

Overview

Standard Life Investments was a leading global asset manager based in Edinburgh, Scotland, and operated as a subsidiary of the Standard Life group. The firm provided a broad range of investment solutions, including actively managed strategies in equities, fixed income, and alternative investments. In 2017, the company merged with Aberdeen Asset Management to form Standard Life Aberdeen, which was subsequently rebranded as abrdn in 2021. As a financial institution, Standard Life Investments does not engage in drug discovery, clinical trials, or medical device manufacturing. Its involvement in the life sciences sector is limited to institutional investment and asset allocation on behalf of its clients.

Industry: Investors

Beyond the preview

Go deeper on Standard Life Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Standard Life Investments.

Explore the full profile